Cargando…
LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
KRAS is the most frequently mutated oncogene in human lung adenocarcinomas (hLUAD), and activating mutations frequently co-occur with loss-of-function mutations in TP53 or STK11/LKB1. However, mutation of all three genes is rarely observed in hLUAD, even though engineered comutation is highly aggres...
Autores principales: | Stein, Benjamin D., Ferrarone, John R., Gardner, Eric E., Chang, Jae Won, Wu, David, Hollstein, Pablo E., Liang, Roger J., Yuan, Min, Chen, Qiuying, Coukos, John S., Sindelar, Miriam, Ngo, Bryan, Gross, Steven S., Shaw, Reuben J., Zhang, Chen, Asara, John M., Moellering, Raymond E., Varmus, Harold, Cantley, Lewis C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068449/ https://www.ncbi.nlm.nih.gov/pubmed/36715544 http://dx.doi.org/10.1158/2159-8290.CD-22-0805 |
Ejemplares similares
-
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1-mutant lung cancer
por: Kim, Jiyeon, et al.
Publicado: (2020) -
Methylglyoxal Forms Diverse Mercaptomethylimidazole
Crosslinks with Thiol and Guanidine Pairs in Endogenous Metabolites
and Proteins
por: Coukos, John S., et al.
Publicado: (2021) -
The pd --> tpi+ reaction in an isobar model: angular distributions
por: Sainio, M E
Publicado: (1981) -
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
por: Unni, Arun M, et al.
Publicado: (2018) -
KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas
por: Gu, Meichen, et al.
Publicado: (2021)